Kate Therapeutics
Fay Naea has extensive experience in accounting and financial analysis, with a background in various companies ranging from pharmaceuticals to compliance operations. With a BS in Business Administration-Accounting from the University of South Alabama, Fay has held roles such as Senior Accounting Manager and Director of Compliance Operations, showcasing their expertise in financial reporting, data analysis, and process improvements.
This person is not in any teams
Kate Therapeutics
Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.